lifestyle.longislandreport.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Penumbra, Inc.
New STORM-PE Data Show Computer Assisted Vacuum Thrombectomy with Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients
April 13, 2026
Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
February 26, 2026
Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results
January 15, 2026
Penumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 29, 2025
Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference
November 24, 2025
Penumbra, Inc. Reports Third Quarter 2025 Financial Results
November 11, 2025
Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary Embolism
November 6, 2025
Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism
October 27, 2025